Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.19 Analyst target: $6.14 Upside: 415.97%
Codexis, Inc. discovers, develops and sells biocatalysts. The company is headquartered in Redwood City, California.
See the full interactive analysis & chart →Informational only — not investment advice.